Efg Capital International Corp. Blueprint Medicines Corp Call Options Transaction History
Efg Capital International Corp.
- $432 Billion
- Q2 2023
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding BPMC
# of Institutions
340Shares Held
62MCall Options Held
987KPut Options Held
578K-
Black Rock Inc. New York, NY6.65MShares$591 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.54MShares$582 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.87MShares$523 Million0.08% of portfolio
-
Wellington Management Group LLP Boston, MA3.24MShares$288 Million0.06% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD2.46MShares$219 Million8.22% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $5.31B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...